BAY-885
/ Bayer
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 25, 2022
BAY-885, a mitogen-activated protein kinase kinase 5 inhibitor, induces apoptosis by regulating the endoplasmic reticulum stress/Mcl-1/Bim pathway in breast cancer cells.
(PubMed, Bioengineered)
- "ER stress was induced in an ERK5 inhibition-dependent manner. These findings suggested that BAY-885 induced apoptosis in BC cells via ER stress/Mcl-1/Bim axis, suggesting that BAY-885 may serve as a therapeutic agent for BC."
Journal • Breast Cancer • Hematological Malignancies • Leukemia • Oncology • Solid Tumor • MCL1
December 21, 2018
Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2-d]pyrimidine based in vitro Probe BAY-885 for the Kinase ERK5.
(PubMed, J Med Chem)
- "ERK5 is a key integrator of cellular signal transduction and it has been shown to play a role in various cellular processes such as proliferation, differentiation, apoptosis and cell survival. We could demonstrate that inhibition of ERK5 kinase and transcriptional activity with a small molecule did not translate into antiproliferative activity in different relevant cell models, which is in contrast to the results obtained by RNAi technology."
Journal • Preclinical
1 to 2
Of
2
Go to page
1